Little is known about the incidence and risk of seizures after stroke in young adults. Especially in the young seizures might dramatically influence prognosis and quality of life. We therefore investigated the long-term incidence and risk of post-stroke epilepsy in young adults with a transient ischemic attack (TIA), ischemic stroke (IS) or intracerebral hemorrhage (ICH).
Methods and Findings
We performed a prospective cohort study among 697 consecutive patients with a first-ever TIA, IS or ICH, aged 18–50 years, admitted to our hospital between 1-1-1980 till 1-11-2010. The occurrence of epilepsy was assessed by standardized questionnaires and verified by a neurologist. Cumulative risks were estimated with Kaplan-Meier analysis. Cox proportional hazard models were used to calculate relative risks. After mean follow-up of 9.1 years (SD 8.2), 79 (11.3%) patients developed post-stroke epilepsy and 39 patients (5.6%) developed epilepsy with recurrent seizures. Patients with an initial late seizure more often developed recurrent seizures than patients with an initial early seizure. Cumulative risk of epilepsy was 31%, 16% and 5% for patients with an ICH, IS and TIA respectively (Logrank test ICH and IS versus TIA p<0.001). Cumulative risk of epilepsy with recurrent seizures was 23%, 8% and 4% respectively (Logrank ICH versus IS p = 0.05, ICH versus TIA p<0.001, IS versus TIA p = 0.01). In addition a high NIHSS was a significant predictor of both epilepsy and epilepsy with recurrent seizures (HR 1.07, 95% CI 1.03–1.11 and 1.08, 95% CI 1.02–1.14).
Post-stroke epilepsy is much more common than previously thought. Especially patients with an ICH and a high NIHSS are at high risk. This calls upon the question whether a subgroup could be identified which benefits from the use of prophylactic antiepileptic medication. Future studies should be executed to investigate risk factors and the effect of post-stroke epilepsy on quality of life.
Citation: Arntz R, Rutten-Jacobs L, Maaijwee N, Schoonderwaldt H, Dorresteijn L, van Dijk E, et al. (2013) Post-Stroke Epilepsy in Young Adults: A Long-Term Follow-Up Study. PLoS ONE 8(2): e55498. https://doi.org/10.1371/journal.pone.0055498
Editor: Cesar V. Borlongan, University of South Florida, United States of America
Received: September 24, 2012; Accepted: December 23, 2012; Published: February 4, 2013
Copyright: © 2013 Arntz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This manuscript was supported by the “Dutch Epilepsy Fund” (grantnumber 2010-18). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
The incidence of epilepsy after stroke in elderly ranges from 2% to 14%, depending on study population, stroke subtype and definitions of epilepsy –. Post-stroke epilepsy has a negative effect on stroke recovery and quality of life –. However information on post-stroke epilepsy is only available from studies containing elderly stroke patients, which can not necessarily be generalized to the young. Especially in young patients with a long life expectancy, seizures might have a dramatic influence on quality of life and disability due to its negative effect on stroke recovery and unpredictability. Due to this unpredictability, work may be considered unsuitable or unsafe by employers, which could ultimately result in unemployment of these young patients. Thereby seizures may not only influence life of the individual patient, but may have an impact on family and community as well . In addition the necessity to use long-term antiepileptic medication might have a particular high impact given their active lives with work, young families and many social activities. Surprisingly little is known about the long-term incidence and risk factors of post-stroke epilepsy after a stroke in young patients. The only studies performed so far were usually small, had a short follow-up and different definitions of post-stroke epilepsy. In addition those studies were not designed to investigate the risk of epilepsy and only included patients with an IS and not those with a TIA or ICH , –.
Quantification of post-stroke epilepsy frequency and risk factors is a first step in both informing young stroke patients and evaluating and developing treatment strategies. The aim of this study was therefore to investigate the long-term incidence and risk of post-stroke epilepsy and epilepsy with recurrent seizures in patients with a TIA, IS or ICH at young age.
Patients and Study Design
This study is part of the “Follow-Up of Transient ischemic attack and stroke patients and Unelucidated Risk factor Evaluation”-study (FUTURE study), a prospective cohort study that investigates causes and consequences of stroke in young adults. Details of the study have been described elsewhere . The Medical Review Ethics Committee region Arnhem-Nijmegen approved the study.
The FUTURE study comprises all consecutive patients with a TIA, IS or ICH, aged 18–50 years, admitted to the Radboud University Nijmegen Medical Centre from 1-1-1980 till 1-11-2010. TIA was defined as a rapidly evolving focal neurological deficit, without positive phenomena such as twitches, jerks or myoclonus, with no other than a vascular cause lasting less than 24 hours. Stroke was defined as focal neurological deficit persisting for more than 24 hours , . On basis of radiological findings, stroke was subdivided into ICH and IS. Exclusion criteria were previous stroke or TIA, traumatic hemorrhagic stroke, hemorrhage in known cerebral metastasis or primary brain tumor, cerebral venous sinus thrombosis, subarachnoid hemorrhage or ICH due to known ruptured aneurysm and retinal infarction. For the present study only patients with a first-ever stroke were included and history of seizures was an additional exclusion criteria.
Patients were included prospectively between 1980 and 2010 with a standardized collection of baseline and clinical characteristics (including demographics, stroke subtype, vascular risk factors and a history of epilepsy). Furthermore all patients underwent neurological examination and brain imaging at the time of their index event . The assessment of stroke etiology (TOAST ) and severity (National Institutes of Health Stroke Scale (NIHSS)  and modified Rankin scale ) was done for all cases retrospectively by a validated approach, ,  as these scales did not exist at the time when a substantial proportion of our patients experienced their qualifying event.
Information on the vital status was available either from the hospital or via the municipality registry. Patients alive were invited for follow-up assessment between 1-11-2009 and 1-1-2012. All patients signed informed consent.
Primary outcome was the occurrence of epilepsy after stroke. Post-stroke epilepsy was defined according to the most recent version of the International League Against Epilepsy (ILAE), in which patients with a single seizure associated with an enduring condition that could cause epilepsy (for example stroke), met the criteria of epilepsy . Seizures were classified as partial (simple, complex and secondary generalized) or generalized . If it was not possible to classify a seizure, this was defined as not otherwise specified. Furthermore seizures were classified according to their time of onset. Seizures occurring within 1 week after stroke were classified as early seizures and seizures occurring thereafter were classified as late seizures . Onset seizures were defined as occurring within 24 hours of onset of stroke . To provide comparability with other studies epilepsy with recurrent seizures was included as a secondary outcome.
All patients alive underwent standardized, structured questionnaires. In case a patient had died, this information was retrieved from the general practitioner by the same structured questionnaires. If seizures were reported, information from the treating physician was retrieved, both for patients alive and patients who died. This information was verified and adjudicated by an experienced neurologist who was blinded for the index event. In addition when patients reported early or onset seizures, this information was verified by medical chart review or by retrieving information from other treating physicians. Information about date of seizure, number of seizures during follow-up and treatment were systematically recorded. Data on outcome were available for all patients.
For comparison of continuous variables between groups students-t-test or Mann-Whitney U test were used when appropriate. In case of categorical variables chi-square-test was used.
Cumulative risks of post-stroke epilepsy and epilepsy with recurrent seizures were estimated with Kaplan-Meier analysis, with the first post-stroke seizure as qualifying endpoint. Patients who died or did not reach the endpoint before follow-up ended were censored. Furthermore as patients with a recurrent stroke or TIA might have a higher risk of epilepsy, they were censored after their recurrent event. Differences between stroke subtype and gender in cumulative risks of post-stroke epilepsy and epilepsy with recurrent seizures were tested with the log rank test.
Average annual risks of epilepsy and epilepsy with recurrent seizures were calculated using the formula 1−[(1−Ic)1/n] where Ic equals the cumulative risk of epilepsy or epilepsy with recurrent seizures at n years, obtained by the Kaplan-Meier method . Cox proportional hazard models were used to calculate hazard ratios with their corresponding 95% confidence intervals for gender, age at event, stroke subtype and NIHSS at admission.
Two-sided P values of less than 0.05 were considered to indicate statistical significance. SPSS 18 was used for all statistical analysis.
1006 patients fulfilled in- and exclusion criteria of the FUTURE study, after inclusion one more patient with an ICH was excluded because after careful reevaluation this appeared to be on the basis of a cerebral venous sinus thrombosis, which was an exclusion criteria for our study. For the present study 697 patients were included in the analysis (Figure 1). Our study included 206 patients with a TIA (29.6%), 425 patients with an IS (61.0%) and 66 patients with an ICH (9.5%). Compared to participants, patients lost to follow-up more often had an IS (76.5% versus 61.0%, p = 0.008) and less often a TIA (13.1% versus 29.0%, p = 0.002). Furthermore patients lost to follow-up were younger (38.1 versus 40.5 years, p = 0.02) and less often had diabetes (2.5% versus 5.7%, p = 0.006). Except for smoking there were no differences in baseline characteristics in patients who refused to participate and participants (53.1% versus 62.0%, p = 0.05).
Participants’ mean age was 40.5 years (SD 7.8) and 47.1% was male. Median NIHSS at admission was 3 (IQR 1–8.5). Of all patients 160 (23.0%) had died after a mean follow-up of 9.1 years (SD 8.2).
Frequency of Post-stroke Epilepsy
79 patients (11.3%) developed post-stroke epilepsy during follow-up (Table 1). In 25 patients the first seizure was an early seizure and thus occurred within 1 week after stroke. In 53 patients the first seizure was a late seizure. Patients with an ICH had the highest incidence of epilepsy (16.7%), followed by IS (14.4%) and patients with a TIA (3.4%). Classification of the first seizure is shown in table 2.
39 Patients (5.6%) had epilepsy with recurrent seizures during follow-up. Patients with an ICH more often developed epilepsy with recurrent seizures (10.6%), followed by IS (6.6%) and TIA patients (1.9%). Patients with an initial late seizure, more often developed recurrent seizures than patients with an initial early seizure (Table 3).
12 out of the 25 patients with an early seizures did not start anti-epileptic drugs (AED’s) during follow-up. 10 Patients started directly after the initial early seizure and 3 patients started after recurrent seizures. Of the 54 patients with an initial late seizure, 7 were not treated with AED’s during follow-up. 37 Started directly after the initial late seizure, 8 started after recurrent seizures and in 2 patients it was unknown when anti-epileptic drugs were started.
Patients with an initial late seizure more often started with AED’s than patients with an initial early seizures (87% versus 52%, p<0.001). Patients with recurrent seizures more often received AED’s than those with a single seizure (94.9% versus 57.5%, p<0.001).
Risk of Post-stroke Epilepsy
After total follow-up of maximum 30 years the cumulative risk of post-stroke epilepsy was 14% (95% CI 10.3–16.6) for all stroke subtypes. Cumulative risk of post-stroke epilepsy was 31%, 16% and 5% for patients with an ICH, IS and TIA respectively (log rank test ICH versus IS and IS versus TIA p<0.001) (Figure 2).
A. Average annual risk of epilepsy. B. Average annual risk of epilepsy with recurrent seizures.
Cumulative risk of epilepsy with recurrent seizures was 7% (95% CI 5.0–10.0). Patients with an ICH (23%) or an IS (8%) had a higher cumulative risk of developing epilepsy with recurrent seizures than patients with a TIA (4%) (Log Rank ICH versus IS p = 0.051, ICH versus TIA p<0.001, IS versus TIA p = 0.013) (Figure 2).
Average annual risk of both epilepsy and epilepsy with recurrent seizures was the highest during the first year after the index event (8% and 4% respectively), especially in patients with an IS or ICH (Figure 3).
A. Overall cumulative risk. B. Cumulative risk according to stroke subtype. C. Cumulative risk according to gender.
High NIHSS at admission and IS or ICH as stroke subtype were significant predictors of post-stroke epilepsy, corrected for age and gender (Table 4). High NIHSS remained a significant predictor for epilepsy with recurrent seizures.
Our study is the first to investigate the incidence and risk of post-stroke epilepsy in young adults with a TIA, IS or ICH. We found an incidence of 11.3% for post-stroke epilepsy and 5.9% for epilepsy with recurrent seizures after a mean follow-up of almost 10 years.
Strengths of our study were the prospective and single centre design, which allowed us to collect information systematically and to uniformly verify both the qualifying event as well as the outcome. Furthermore, our study has one of the longest follow-up ever reported and the largest cohort compared with other studies investigating epilepsy after a stroke in young adults. In addition, our study has a high external validity, when comparing baseline characteristics to other studies .
However there are also a few limitations. Some selection bias may have occurred due to selective loss to follow-up. Those lost to follow-up more often had an IS and less often a TIA compared to participants. Potentially, this might have resulted in an underestimation of the overall risk of epilepsy in our cohort, as patients with an IS exhibited a higher risk of post stroke epilepsy. However, the severity of stroke did not differ between participants and those lost to follow-up, so we considered this loss of follow-up very unlikely to influence our results. Patients who refused to participate did not differ in baseline characteristic from participants except from smoking, making selection bias in this group for the same reason unlikely.
As information on seizures was collected by structured questionnaires for all patients in the same way, it is unlikely that seizures are reported differently between the stroke subtypes, which makes information bias very unlikely. Furthermore the neurologist verifying the event was blinded for the index event. Since the present study features a long inclusion period recall bias might have influenced our findings, especially when the index event or seizure occurred a longer time ago. However there were no differences in reporting seizures between patients who suffered their stroke a long time ago than those with a more recent stroke (9.0% in 2000–2010 versus 16.0% in 1990–1999 versus 11.6% in 1980–1989, p = 0.055), making recall bias unlikely. In addition it might have been possible that less information would be available in patients who died, especially in those who died a longer time ago, resulting in an underestimation of epilepsy in this group. However we did not find a difference in frequency of epilepsy between patients who died a long time ago and those who died more recently (12.5% in 1980–1989 versus 16.3% in 1990–1999 versus 16.7 in 2000–2010, p = 0.882), making this explanation unlikely. On top of this, information on patients who died before follow-up ended was collected in an identical manner as in patients alive.
Another source of bias might be misclassification of TIA patients. In some cases it might be difficult to distinguish a TIA from a seizure, especially for example in case of a limb-shaking TIA . Theoretically either the index event or the seizure could have been misclassified. In our study all qualifying events were verified by two independent neurologists, independent from the outcome. In addition, 5 out of 8 patients developed complex partial seizures or (secondary) generalized seizures, which can be easily distinguished from TIA’s, so it is unlikely that those were misdiagnosed.
Another source of bias to be considered is confounding. We tried to overcome this by making appropriate adjustments for potential confounders including age, stroke severity, gender and stroke subtype in our multivariate analysis. Furthermore we have adjudicated for recurrent stroke or TIA, by withdrawing patients after a recurrent event in the Kaplan-Meier analysis.
Another possible confounding factor might have been the use of AED’s. In our study 10 out of 25 patients with an early seizure and 37 out of 54 patients with an initial late seizure started directly after the first seizure with AED’s. It might be possible that the use of AED’s has reduced the risk of epilepsy with recurrent seizures after a single seizures. However as AED’s were not prescribed prophylactic, only the frequency of epilepsy with recurrent seizures might have been affected by the use of AED’s and not the incidence of the first seizure. In addition the impact of AED’s on epileptogenesis remains unclear. Furthermore during 30 years of follow-up patients may have switched or stopped AED’s, which may have provoked or prevented occurrence of seizures as well.
According to the new definition of the ILAE patients already meet the criteria of epilepsy when a single seizure occurs with an enduring cause. Most other studies still use the former version in which patients meet the diagnosis of epilepsy when they have at least 2 (late) seizures. For reasons of comparability, we therefore compared the risks of seizures in previous studies with the risk of epilepsy in our study. We found a higher incidence of post-stroke epilepsy compared to other studies that investigated seizures stroke in young adults (6–10%) , –. This may be explained by the characteristics of our study. Except for IS and TIA patients we included patients with an ICH who had a higher cumulative risk of post-stroke epilepsy and epilepsy with recurrent seizures, whereas other studies only included ischemic strokes. For patients with an IS incidence of post-stroke epilepsy was almost 15% in our study, while others reported incidences of seizures between 6–10% , –. This difference may, in part, be explained by the far longer follow-up of our patients, leaving them more time to develop epilepsy. However a higher risk was found especially during the first years after the index event.
Compared to other studies in elderly with more or less the same definitions we found a higher incidence of epilepsy and epilepsy with recurrent seizures (3.4% to 10.4% and 2% to 5% respectively) , , , , . Compared to the few studies in both young and elderly stroke patients which performed survival analysis, cumulative risk of post-stroke epilepsy and epilepsy with recurrent seizures was higher after same follow-up , , , .
The higher cumulative risk of post-stroke epilepsy and epilepsy with recurrent seizures in our young cohort may presumably be due to mechanisms in young patients which makes them more vulnerable for the development of epilepsy. This is also suggested by few other studies among elderly who found a higher incidence of seizures in younger patients, after stratification in several age groups –. It was suggested that the brain of elderly patients might have a weaker epileptogenicity , however there is no proper explanation for this finding yet.
Interestingly, in our study patients with a TIA had comparable risk of epilepsy than shown in studies among elderly TIA patients , , –. Despite the potential of misclassification of TIA patients, TIA was diagnosed according to current clinical guidelines and patients with positive phenomena such as twitches, jerks or myoclonus were excluded in order to minimize this, the only way to assess the risk of epilepsy after TIA is by including these patients in a study and ours is the first to do so.
Few studies found comparable incidences of early seizures, , –,  however definitions of early seizures in those studies varied from 24 hours until 2 weeks, which obviously influences the incidence. In line with another study, we found that patients with initial late seizures more often developed epilepsy with recurrent seizures than those with initial early seizures . One explanation might be the effect of survival, however there was no difference in survival between patients with an initial early and initial late seizure. In our opinion late seizures have a greater clinical importance, as those seizures very much influence daily life when patients are trying to rebuild their normal activities. In addition it has been suggested that pathophysiology of early and late seizures might be different. Early seizures might be related to non-cerebral disarrangements and thought to result from cellular biochemical dysfunction , , . Late seizures on the other hand are suggested to be a result of gliosis or hemosiderin remaining .
As in other cohorts a higher cumulative risk epilepsy and epilepsy with recurrent seizures was found in patients with an ICH. In addition a high NIHSS was a significant predictor of both epilepsy and epilepsy with recurrent seizures , , , , , .
In conclusion, we showed that epilepsy and epilepsy with recurrent seizures are much more common after a stroke in young adults than previously described. Future studies should be executed to investigate risk factors and the underlying pathophysiology. Besides this, these studies should also investigate the effect of post-stroke epilepsy on quality of life. Furthermore, the high cumulative risk of epilepsy is as high as the risk of recurrent stroke . This calls upon the question whether a subgroup could be identified, which would benefit from prophylactic AED’s, especially during the first years after stroke during which the risks are the highest.
Critical revision of the manuscript: RA LR NM LD HS EvD FdL. Conceived and designed the experiments: FdL EvD LD HS. Performed the experiments: RA LR NM FdL EvD. Analyzed the data: RA FdL. Wrote the paper: RA FdL EvD.
- 1. Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E (1997) Predictive factors of early seizures after acute cerebrovascular disease. Stroke 28: 1590–1594.
- 2. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, et al. (1997) Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. Bmj 315: 1582–1587.
- 3. Lamy C, Domigo V, Semah F, Arquizan C, Trystram D, et al. (2003) Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 60: 400–404.
- 4. Lossius MI, Ronning OM, Slapo GD, Mowinckel P, Gjerstad L (2005) Poststroke epilepsy: occurrence and predictors–a long-term prospective controlled study (Akershus Stroke Study). Epilepsia 46: 1246–1251.
- 5. Reith J, Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS (1997) Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke 28: 1585–1589.
- 6. So EL, Annegers JF, Hauser WA, O’Brien PC, Whisnant JP (1996) Population-based study of seizure disorders after cerebral infarction. Neurology 46: 350–355.
- 7. Labovitz DL, Hauser WA, Sacco RL (2001) Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 57: 200–206.
- 8. Arboix A, Comes E, Massons J, Garcia L, Oliveres M (1996) Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology 47: 1429–1435.
- 9. Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, et al. (2000) Seizures after stroke: a prospective multicenter study. Arch Neurol 57: 1617–1622.
- 10. Burneo JG, Fang J, Saposnik G (2010) Impact of seizures on morbidity and mortality after stroke: a Canadian multi-centre cohort study. Eur J Neurol 17: 52–58.
- 11. de Boer HM, Mula M, Sander JW (2008) The global burden and stigma of epilepsy. Epilepsy Behav 12: 540–546.
- 12. Leys D, Bandu L, Henon H, Lucas C, Mounier-Vehier F, et al. (2002) Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology 59: 26–33.
- 13. Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM (2004) Long-term outcome of cerebral infarction in young adults. Acta Neurol Scand 110: 107–112.
- 14. Neau JP, Ingrand P, Mouille-Brachet C, Rosier MP, Couderq C, et al. (1998) Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis 8: 296–302.
- 15. Varona JF, Bermejo F, Guerra JM, Molina JA (2004) Long-term prognosis of ischemic stroke in young adults. Study of 272 cases. J Neurol 251: 1507–1514.
- 16. Rutten-Jacobs LC, Maaijwee NA, Arntz RM, Van Alebeek ME, Schaapsmeerders P, et al. (2011) Risk factors and prognosis of young stroke. The FUTURE study: A prospective cohort study. Study rationale and protocol. BMC Neurol 11: 109.
- 17. A classification and outline of cerebrovascular diseases II. Advisory Council for the National Institute of Neurological and Communicative Disorders and Stroke Stroke 6: 564–616.
- 18. Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54: 541–553.
- 19. Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, et al. (2009) Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovasc Dis 27: 509–518.
- 20. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, et al. (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20: 864–870.
- 21. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19: 604–607.
- 22. Williams LS, Yilmaz EY, Lopez-Yunez AM (2000) Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke 31: 858–862.
- 23. Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, et al. (1999) Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke 30: 1534–1537.
- 24. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, et al. (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46: 470–472.
- 25. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, et al. (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 51: 676–685.
- 26. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 34: 592–596.
- 27. Hankey GJ, Slattery JM, Warlow CP (1991) The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry 54: 793–802.
- 28. Putaala J, Haapaniemi E, Metso AJ, Metso TM, Artto V, et al. (2010) Recurrent ischemic events in young adults after first-ever ischemic stroke. Ann Neurol 68: 661–671.
- 29. Schulz UG, Rothwell PM (2002) Transient ischaemic attacks mimicking focal motor seizures. Postgrad Med J 78: 246–247.
- 30. Kammersgaard LP, Olsen TS (2005) Poststroke epilepsy in the Copenhagen stroke study: incidence and predictors. J Stroke Cerebrovasc Dis 14: 210–214.
- 31. Paolucci S, Silvestri G, Lubich S, Pratesi L, Traballesi M, et al. (1997) Poststroke late seizures and their role in rehabilitation of inpatients. Epilepsia 38: 266–270.
- 32. Szaflarski JP, Rackley AY, Kleindorfer DO, Khoury J, Woo D, et al. (2008) Incidence of seizures in the acute phase of stroke: a population-based study. Epilepsia 49: 974–981.
- 33. Camilo O, Goldstein LB (2004) Seizures and epilepsy after ischemic stroke. Stroke 35: 1769–1775.
- 34. Krakow K, Sitzer M, Rosenow F, Steinmetz H, Foerch C (2010) Predictors of acute poststroke seizures. Cerebrovasc Dis 30: 584–589.
- 35. De Herdt V, Dumont F, Henon H, Derambure P, Vonck K, et al. (2011) Early seizures in intracerebral hemorrhage: Incidence, associated factors, and outcome. Neurology 77: 1794–1800.
- 36. Luhmann HJ (1996) Ischemia and lesion induced imbalances in cortical function. Prog Neurobiol 48: 131–166.
- 37. Beghi E, D’Alessandro R, Beretta S, Consoli D, Crespi V, et al. (2011) Incidence and predictors of acute symptomatic seizures after stroke. Neurology 77: 1785–1793.